Learn how to utilize incretin therapy (including GLP1 receptor agonist and dual incretin receptor agonists) in your practice for type 2 diabetes. This will cover: pathophysiology, mechanism of action, indications for use, dose titration and side effect management. We will also discuss safety and efficacy data as well as secondary indications/benefits beyond improving glycemic control.
I graduated from PA school from Pacific University in 2013. I
have practiced in diabetes and endocrinology for the vast majority of my
career- all of this in Western Montana. I truly enjoy chronic disease
management and getting to know and work with my patients over many
years/decades. When not practicing, I can be found in the outdoors, running,
mountain biking or skiing with my husband and two young children.
For any questions, clarifications, or follow up, please contact MNA at info@mtnurses.org
Montana Nurses Association is approved with distinction as a provider of nursing continuing professional development by the Virginia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
To earn contact hours, learners must watch the entire webinar and submit an evaluation and digital certificate claim form after the session.
There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity except for Brenda Donaldson who owned stock in Pfizer Company. All relevant financial relationships have been mitigated.
Expires 12/31/2026
Contact hours awarded upon successful completion: 1 CH, 1 Rx hour
